Grounded in data-driven human insights and representing the perspectives of both patients and HCPs, medical affairs can ...

AstraZeneca and CSPC Pharmaceuticals have announced a new collaboration agreement for the development of therapies for obesity and type 2 diabetes.

Genentech has doubled its initial investment in a new manufacturing facility located in Holly Springs, North Carolina, bringing investment in the project to around $2bn.

The state of California in the US is suing the nation’s largest insulin manufacturers and pharmacy benefit managers (PBMs) for allegedly using their market power to overcharge patients for the ...

GC Therapeutics has appointed Kate Haviland as Board Chair.

AstraZeneca has announced a $15bn investment in China by 2030 to expand manufacturing and R&D.

Genentech has announced positive topline results from a phase 2 trial of CT-388, its investigational therapy to treat obesity ...

Tamer Mohamed, founder and CEO at Aspect Biosystems added: “Our partnership with Novo Nordisk combines more than a century of their global leadership in the fight against diabetes with Aspect’s ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...